ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: TH-PO600

A Systems Biology Approach Identifies Reciprocal Changes in mir-193b-3p and PIK3R1 as Drivers of Cyst Growth in ADPKD

Session Information

Category: Genetic Diseases of the Kidney

  • 801 Cystic Kidney Diseases

Authors

  • Vergoz, Laura, University of Sheffield, Sheffield, United Kingdom
  • Streets, Andrew J., University of Sheffield, Sheffield, United Kingdom
  • Malas, Tareq B, Leiden University Medical Center, Leiden, Netherlands
  • Lannoy, Morgane, University of Sheffield, Sheffield, United Kingdom
  • 't Hoen, Peter A, Leiden University Medical Center, Leiden, Netherlands
  • Peters, Dorien J.M., Leiden University Medical Center, Leiden, Netherlands
  • Ong, Albert C., University of Sheffield, Sheffield, United Kingdom
Background

Autosomal dominant polycystic kidney disease (ADPKD) is the most common inherited cause of end-stage renal disease worldwide. PKD1 and PKD2 mutations are present in most patients with clear genotype-phenotype correlations. However, the intra-familial phenotypic variability in some pedigrees suggests the influence of non-allelic factors. Non-coding RNAs e.g. microRNAs are known to play a major role in health and disease (including PKD) via control of mRNA stability or translation. We recently conducted a parallel mRNA/miRNA array study which found mir-193b-3p, among others, downregulated in human ADPKD cells (Streets et al, 2017), associated with dysregulation of the ErbB4/EGF pathway.

Methods

To select other relevant genes regulated by mir-193b-3p, we compared our human mRNA dataset with mRNA expression data from Pkd1 mutant mice (Malas et al, 2017). Dual-reporter luciferase assays with native and mutant seed sequences and immunoblotting were used to demonstrate functional binding of mir-193b-3p to the 3’UTR of PIK3R1 mRNA. IGF-1 stimulation of human ADPKD cystic cells in 2D and 3D cultures characterized the role of PIK3R1 in Akt or ERK signaling and on cyst growth.

Results

PIK3R1 was selected as a strong candidate gene and shown to be upregulated ~3-fold in human cells and mouse Pkd1 kidney tissue. In parallel, the catalytic subunit PIK3CA was also overexpressed suggesting the most common PI3K enzyme combination is upregulated in ADPKD cells. A functional interaction between PIK3R1 and mir-193b-3p was confirmed by luciferase assays and immunoblotting. Knockdown of PIK3R1 or PI3K chemical inhibitors significantly reduced cyst growth in ADPKD cells and influenced Akt and ERK activation by IGF-1.

Conclusion

We report that PIK3R1 and one of its catalytic subunits are upregulated in ADPKD and confirm that it is a target for mir-193b-3p. The role of PIK3R1/PIK3CA in driving cyst growth in ADPKD was functionally linked to hyperactivation of Akt and ERK. Co-regulation of PIK3R1 and ErbB4 by mir-193b-3p supports the development of PI3K and ErbB4 inhibitors or mir-193b-3p activators for the treatment of ADPKD.

Funding

  • Government Support - Non-U.S.